Chemistry

Drugs of Abuse Testing

A chronically relapsing disorder, drug addiction is characterized by the compulsive use of addictive substances, despite adverse consequences to the individual and society 1 , making reliable testing for drugs of abuse needed now more than ever.

A Growing Global Issue

The amount of drug usage is increasing around the globe 3, and with it grows the number
of illicit drug use and drug-abuse-related deaths.5

Drug-Abuse-Testing-Infographic

Menu Offering

Expanded Drugs of Abuse:

  • 6- acetylmorphine*
  • Amphetamines*
  • Barbiturates*
  • Barbiturate Serum Tox*
  • Benzodiazepine*
  • Benzodiazepine Serum Tox*
  • Buprenorphine*
  • Cannabinoid*
  • Cocaine Metabolite*
  • Ecstasy*
  • Ethyl Alcohol*
 
  • Fentanyl**
  • Hydrocodone**
  • Ketamine**
  • LSD*
  • Methadone*
  • Methaqualone*
  • Opiate*
  • Phencyclidine*
  • Propoxyphene*
  • Tricyclics Serum Tox*
*manufactured by Siemens , **manufactured by Lin-Zhi

 


Introducing Three New Esoteric Drugs of Abuse Testing Assays

Intended for the qualitative or semi-quantitative determination of norfentanyl in human urine. It’s the only assay that can measure norfentanyl up to 100% cross-reactivity at a low cutoff of 5 ng/mL
Intended for the qualitative or semi-quantitative determination of hydrocodone in human urine at a cutoff of 300 ng/mL.
Intended for the qualitative or semi-quantitative determination of norketamine in human urine at the cutoff values of 50ng/mL.

Why is Drug Testing Important? With new substances emerging and global drug abuse rising, accurate drug testing is essential.

BROCHURE
The Global Drug Market Grows Complex as New Substances Emerge

The lines between legal and illegal drug markets are becoming increasingly blurred. Learn more about the need for laboratory adaptation and our extensive drug abuse test menu.

BLOG
The Rising Problem of Drug Abuse and the Need for Detection that Matters

Drug abuse around the world is on the rise and there is a demand for robust drug detection and monitoring solutions throughout institutions globally.

Address a Greater Demand

Meet the testing demands for drugs-of-abuse detection and therapeutic drug monitoring in your laboratory with a comprehensive menu of assays.

Scalable Chemistry Solutions to Meet Any Workload

Consolidate testing and experience the flexibility to choose the right instrument and reagent combination to suit your laboratory's on-site requirements. Our comprehensive therapeutic drug monitoring and drugs-of-abuse menus run on the following Beckman Coulter Clinical Chemistry Analyzers:

Would you like more information on our drug of abuse testing solutions?
Let’s connect.

References:
Products listed may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information
1. Complications | ADA. (2021). American Diabetes Association. https://www.diabetes.org/diabetes/complications 
2. IDF Diabetes Atlas 9th edition 2019. (2019). International Diabetes Federation. https://diabetesatlas.org/en/ 
3. Worldwide toll of diabetes. (2019). International Diabetes Federation. https://diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html
4. Individual, social and economic impact. (2019). International Diabetes Federation. https://diabetesatlas.org/en/sections/individual-social-and-economic-impact.html#:~:text=Diabetes increases the risk of,one death every eight seconds. 
5. HbA1c (Hemoglobin A1c) Instructions for Use (IFU). B00389. Beckman Coulter, Inc. February 2021.
6. HbA1c (Hemoglobin A1c) Advanced Instructions for Use (IFU). B93009. Beckman Coulter, Inc. February 2021.
7. Access C-Peptide Instructions for Use (IFU). C33451. Beckman Coulter, Inc. February 2021.
8. Fructosamine Liquid Instructions for Use (IFU). 1735001. Beckman Coulter, Inc. February 2021.
9. When Should You Order a Serum Fructosamine Level for a Diabetic Patient? – Clinical Correlations. (2007, March 14). Clinical Correlations. https://www.clinicalcorrelations.org/2007/03/14/when-should-you-order-a-serum-fructosamine-level-for-a-diabetic-patient/#:~:text=Fructosamine testing has been available,diabetics control their blood sugar.&text=The American Diabetes Association (ADA,A1C cannot be reliably measured.
10. This product is not available in the United States at this time. Please contact your Beckman Coulter sales representative or distributor for more information.
11. Editorial Staff. (2019, August 8). The Best Tests to Diagnose Diabetes. UC Berkeley School of Public Health: Health and Wellness Alerts. https://www.healthandwellnessalerts.berkeley.edu/topics/diabetes/the-best-tests-to-diagnose-diabetes/#:~:text=Fasting plasma glucose test measures,initial diagnostic method for decades. 
12. Editorial Staff. (2019, August 8). The Best Tests to Diagnose Diabetes. UC Berkeley School of Public Health: Health and Wellness Alerts. https://www.healthandwellnessalerts.berkeley.edu/topics/diabetes/the-best-tests-to-diagnose-diabetes/#:~:text=Fasting plasma glucose test measures,initial diagnostic method for decades. 
13. Urine Albumin Screening and Monitoring in Type 2 DM. (2009). IHS Division of Diabetes Treatment and Prevention. https://www.ihs.gov/sites/diabetes/themes/responsive2017/display_objects/documents/algorithms/DM_algorithm_Urine_Alb_508c.pdf 
14. Urine/CSF Albumin Instructions for Use (IFU). B38858. B46435. Beckman Coulter, Inc. February 2021.
15. Diabetes - Symptoms and causes. (2020, October 30). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444
16. Sortso, C., Komkova, A., Sandbæk, A., Griffin, S. J., Emneus, M., Lauritzen, T., & Simmons, R. K. (2018). Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Springermedizin.De. https://www.springermedizin.de/effect-of-screening-for-type-2-diabetes-on-healthcare-costs-a-re/15542004?fulltextView=true 
17. Diabetes - Symptoms and causes. (2020b, October 30). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444
18. Global report on diabetes. (2016). World Health Organization. https://www.who.int/publications/i/item/9789241565257/ 
19. IDF Diabetes Atlas, Eighth Edition, 2017.
20. International Expert Committee, 2009. International Expert Committee report on the Role of the A1C assay in the Diagnosis of Diabetes. Diabetes Care, 32(7), pp. 1327-1334.
21. NGSP: HbA1c Assay Interferences. (2020, August). NGSP. http://www.ngsp.org/interf.asp
22. Diabetes Care 2018: 41 (Supplement 1): S13-S27. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes, 2018. 
23. The WHO Logo and Emblem. (2021). World Health Organization. https://www.who.int/about/who-we-are/publishing-policies/logo 
24. Home | ADA. (2021). American Diabetes Association (ADA). https://www.diabetes.org/
25. American Diabetes Association, 2010. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, Volume 33, pp. 62-69.
26. International Expert Committee, 2009. International Expert Committee report on the Role of the A1C assay in the Diagnosis of Diabetes. Diabetes Care, 32(7), pp. 1327-1334.
27. WHO, n.d. World Health Organization (WHO). [Online] Available at: http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/[Accessed 01 May 2017].